Quantum Computing Stocks Rally on Wall Street, Prompting Valuation Debate

Post by : Bianca Suleiman

Market activity on Wall Street has intensified as pure-play quantum computing shares climbed sharply, drawing attention from both retail and institutional investors. Companies such as Rigetti, IonQ, D-Wave, and Quantum Computing Inc. are vying to convert quantum theory into practical systems that can tackle problems beyond the reach of conventional computers.

The surge has produced outsized returns this year, with some stocks jumping more than 100% and prompting comparisons to a tech rush. Rigetti, for example, climbed from $1.06 a share to an intraday high near $58 before settling around $38—despite only modest revenue and persistent unprofitability. By contrast, established firms like Nvidia trade at roughly 50 times sales, highlighting the sector's elevated valuations.

The Promise of Quantum Innovation

Quantum computing could reshape multiple industries, from undermining current cryptography to shortening drug development timelines. Large financial and technology players are already positioning themselves: JPMorgan Chase has set aside up to $10 billion for strategic investments, while IBM, working with HSBC, is exploring quantum approaches for algorithmic bond trading.

Yet the excitement sits alongside a reality check. Analysts note that optimism often outpaces fundamentals. Rigetti, for instance, projects just $21.9 million in revenue for 2026 while carrying a market capitalization near $13 billion—a disparity that has analysts and investors questioning current price levels.

Volatility and Valuation Challenges

The so-called “Quantum 4” names have become highly traded, with Rigetti briefly surpassing established tech giants such as Apple and Amazon in trading volume. Observers say assigning fair value to these companies is ‘‘more art than science,’’ given the uncertainty around the timeline for commercial viability.

Investor sentiment is split: some buy into the long-term transformational case, while others warn of speculative excess given slow operational progress. The trajectory of the sector will likely depend on technological breakthroughs, continued government and corporate investment, and investor patience as these firms attempt to translate scientific promise into commercial returns.